JOHN WILLIS: Open Payments
NPI 1205891207 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 26 payments from 10 companies in 2025. Trend: 2023 $35 · 2024 $386 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $99 |
| Lilly USA, LLC | 5 | $96 |
| PFIZER INC. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Novo Nordisk Inc | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Indivior Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Alkermes, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: JARDIANCE, FREESTYLE LIBRE, PREVNAR 20, SUBLOCADE, Ozempic, AIRSUPRA, MOUNJARO, PROCLAIM.
Industry payments across TX — which companies pay providers there.
